In conclusion, the protective effects of YIGSR on the epithelial barrier function and cell-cell contact were primarily accomplished by binding to 67LR, improving lymphedema also accompanied with the reduction in TGFβ expression levels. This evidence concerns the gene TGFB1 and lymphedema.